Preventive medical services not covered by public health insurance at Daiko Medical Center in Japan, 2004-2011.

The final eradication rate was 80.0% (n=90) for the period before the test introduction, and 88.9% (n=144) for the period after it; the difference was marginally significant (χ 2 =3.52, p=0.06), which was similar to a previous result (p=0.08). 2 ) The eradication rate was 100% (n=53) among those with CYP2C19 *1*1 treated by the second-line regimen ( Table 3 ).

also in 26,082 other papers